• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 0.26% Nasdaq Up 0.23%

    Antares Pharma Inc. (ATRS)

    -NasdaqCM
    2.39 Down 0.02(0.83%) May 4, 4:00PM EDT
    Add to Portfolio
    Prev Close:2.41
    Open:2.40
    Bid:2.35 x 500
    Ask:3.38 x 200
    1y Target Est:5.13
    Beta:1.85
    Earnings Date:May 7 - May 11 (Est.)
    Day's Range:2.35 - 2.50
    52wk Range:1.82 - 3.20
    Volume:482,265
    Avg Vol (3m):579,805
    Market Cap:314.88M
    P/E (ttm):N/A
    EPS (ttm):-0.27
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for ATRS

    Comparison

    Symbol% ChgMkt Cap
    ATRSDown 0.83%314.88M
    BDXUp 1.23%30.06B
    BJCTDown 6.67%1.85M

    Key Statistics

    Forward P/E (1 yr):26.56
    P/S (ttm):11.98
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.12
    Quarterly EPS Est (Mar-15) :-0.05
    Mean Recommendation*:1.3
    PEG Ratio (5 yr expected):-0.26

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Antares Pharma, Inc. operates as a specialty pharmaceutical company that focuses on developing and commercializing self-administered parenteral pharmaceutical products and technologies worldwide. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback